2001.09 – 2005.07          School of the Environment, Nanjing University/ B.S

Vaccines against emerging respiratory viruses, Genetic vectors based on human adenovirus

Dr. Feng’s group is focused on vaccines against respiratory infectious diseases and genetic vectors based on human adenoviruses. Dr. Feng and his team have been developing several novel vaccine strategies using HAdV vectors, for the prevention of emerging viruses such as Ebola and Zika virus. He has published more than 10 peer reviewed papers in international journals including “Emerging Microbes & Infections”, “NPJ Vaccines”, “Journal of Virology”, and “Virology”. Dr. Feng has been undertaking several national and local research programs, such as the grants from National Natural Science Foundation of China (No. 31470892), National Key Research and Development Project (No. 2016YFC1200900), National Science and Technology Major Projects of China (No. 2017ZX10204401003), and Guangzhou Health Care and Cooperative Innovation Major Project. Dr. Feng was selected as the member of CAS Youth Innovation Promotion Association in 2014, and was awarded the Pearl River S&T Nova Program of Guangzhou.

1. Xianmiao Ye, Lijun Xiao, Xuehua Zheng,？？？？？, Ling Chen*,Liqiang Feng*. Seroprevalence of Neutralizing Antibodies to Human Adenovirus Type 4 and 7 in Healthy Populations from Southern China. Frontiers in Microbiology. 2018 Dec 10;9:3040.

2. Xinglong Liu, Linbing Qu, Xianmiao Ye, ？？？？？, Liqiang Feng*, Ling Chen*. Incorporation of NS1 and prM/M are important to confer effective protection of adenovirus-vectored Zika virus vaccine carrying E protein. npj Vaccines. 2018 Jul 24;3:29

3. Yupeng Feng, ？？？？？, Liqiang Feng*, Ling Chen*. An adenovirus serotype 2-vectored ebolavirus vaccine generates robust antibody and cell-mediated immune responses in mice and rhesus macaques. Emerging Microbes Infections. 2018 Jun 6;7(1):101

4. Ying Feng, Xikui Sun, ？？？？？, Ling Chen*, Liqiang Feng*. Hexon and fiber of adenovirus type 14 and 55 are major targets of neutralizing antibody but only fiber-specific antibody contributes to cross-neutralizing activity. Virology. 2018 May;518:272-283

5. Yiling Zhang, Ying Feng, Liang Li, ？？？？？, Ling Chen*, Liqiang Feng*. Immunization with an adenovirus-vectored TB vaccine containing Ag85A-Mtb32 effectively alleviates allergic asthma. Journal of Molecular Medicine. 2018 Apr;96(3-4):249-263